Skip to main content
Cardiovascular & Hematological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders) was previously published as Current Drug Targets - Cardiovascular & Hematological Disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 1, 2018

Articles

Free Content Graphical Abstracts
pp. i-iv(4)

Favourites:
ADD

Free Content Meet Our Associate Editor
pp. 1-1(1)
Author: Beltowski, Jerzy

Favourites:
ADD

Editorial

Review article

Favourites:
ADD

Connexin43 and Myocardial Ischemia-Reperfusion Injury
pp. 14-16(3)
Authors: Zu, Lingyun; Wen, Ningxin; Liu, Changjie; Zhao, Mingming; Zheng, Lemin

Favourites:
ADD

Epicardial Adipose Tissue: Another Tassel in the Complex Fabric of Atherosclerosis
pp. 17-26(10)
Authors: Alexopoulos, Nikolaos; Raggi, Paolo

Favourites:
ADD

Cholesterol Homeostasis and Liver X Receptor (LXR) in Atherosclerosis
pp. 27-33(7)
Authors: Guo, Shuyuan; Li, Luxiao; Yin, Huiyong

Favourites:
ADD

The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
pp. 34-51(18)
Authors: Fulmer, Makenzie L.; Thewke, Douglas P.

Favourites:
ADD

Immunomodulatory and Anti-inflammatory Effects of Thymoquinone
pp. 52-60(9)
Authors: Shaterzadeh-Yazdi, Hanieh; Noorbakhsh, Mohammad-Foad; Hayati, Farzad; Samarghandian, Saeed; Farkhondeh, Tahereh

Favourites:
ADD

Research article

Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells
pp. 61-70(10)
Authors: Ochin, Chinedu C.; Garelnabi, Mahdi

Favourites:
ADD

Glucose Lowering Activity of Anvillea Radiata Coss & Durieu in Diabetic Rats
pp. 71-80(10)
Authors: Hebi, Morad; Eddouks, Mohamed

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content